Genistein for mild memory loss in early Alzheimer's
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests if a supplement called genistein can help people with mild memory problems caused by early Alzheimer's disease. You must have a brain scan showing amyloid buildup and be otherwise healthy enough to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 50 years old.
- You have been diagnosed with mild cognitive impairment (mild memory loss) likely due to Alzheimer's disease.
- Your memory and thinking tests show mild decline, but you can still do your daily activities.
- A recent brain PET scan shows amyloid plaques (a sign of Alzheimer's).
- You are not taking isoflavone supplements and have no history of hormone-related cancer or significant stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This trial tests whether a dietary supplement made from olive polyphenols, combined with following a Mediterranean diet, can help protect thinking and memory in people with mild cognitive impairment (MCI). It may be a good fit if you have early memory changes and want to try a nutrition-based approach.
This Phase 1 study tests whether Centella asiatica (a plant-based supplement) is safe and reaches its intended target in people with mild cognitive impairment or early Alzheimer’s disease. It also checks how it affects memory-related brain measures like MRI scans, which is why multiple scans are required.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.